Pediatric

FDA Considers Revoking Pfizer’s Covid Vaccine Approval for Under-5s: What This Means for Pediatric Health and Pharma Investors

FDA may pull authorization of Pfizer Covid shot for children under 5

Pfizer’s Covid-19 vaccine for healthy children under 5 is on the brink of losing FDA authorization—a development that could reshape pediatric vaccination strategies and ripple through the biotech and healthcare investment landscape. At Extreme Investor … Read more

CDC Vaccine Panel Endorses Merck’s RSV Shot for Infants: A Potential Game-Changer in Pediatric Health and Pharma Investments

Merck’s New RSV Shot: A Game-Changer for Infant Health and What It Means for Investors The recent unanimous recommendation by the revamped Advisory Committee on Immunization Practices (ACIP) to include Merck’s Enflonsia in the government’s … Read more